Estadístiques de Ligelizumab for chronic spontaneous urticaria
Visites totals
| views | |
|---|---|
| Ligelizumab for chronic spontaneous urticaria | 127 |
Visites totals per mes
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
Visites al fitxer
| views | |
|---|---|
| maurer-nej-lige.pdf(legacy) | 351 |
| maurer-nej-lige.pdf | 30 |
Vistes principals per país
| views | |
|---|---|
| United States | 86 |
| Spain | 12 |
| Australia | 5 |
| South Korea | 5 |
| Sweden | 5 |
| Germany | 4 |
| China | 2 |
| United Kingdom | 2 |
| Argentina | 1 |
| Belgium | 1 |
| Ecuador | 1 |
| Malaysia | 1 |
Visites principals per ciutat
| views | |
|---|---|
| San Ramon | 14 |
| Ann Arbor | 11 |
| Boardman | 11 |
| Ashburn | 9 |
| Menlo Park | 9 |
| Barcelona | 3 |
| Fairfield | 3 |
| Cambridge | 2 |
| Greensboro | 2 |
| San Diego | 2 |
| Seongnam | 2 |
| Seoul | 2 |
| Torremolinos | 2 |
| Daegu | 1 |
| Guayaquil | 1 |
| Kuala Lumpur | 1 |
| London | 1 |
| Mountain View | 1 |
| New York | 1 |
| Pinjarra | 1 |
| Rochester | 1 |
| Suipacha | 1 |